DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Melum E, Karlsen TH, Bergquist A. et al.
An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis.
The American journal of gastroenterology 2008;
103: 1045 ; author reply 6
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.